The National Academies Testimony before Congress

Public Laws Containing Studies for the National Academies

Briefings to Congress

Congressionally Mandated Reports

Policy Statements and Historical Documents

The OCGA staff

THE NATIONAL ACADEMIES
Institute of Medicine
Board on Population Health and Public Health Practice
Committee on the Public Health Effectiveness of the FDA 510 (k) Clearance Process

*****

Congressional Briefings
Thursday, July 28, 2011
305 Hart Senate Office Bldg. -- 11:00 a.m.
309 Hart Senate Office Bldg. – 12:00 p.m.
430 Dirksen Senate Office Bldg. – 2:00 p.m.
G31 Dirksen Senate Office Bldg. – 3:00 p.m.
and
2321 Rayburn House Office Bldg. – 4:30 p.m.

and

Monday, August 1, 2011
430 Dirksen Senate Office Bldg. 10:00 a.m.

on

Medical Devices and the Public's Health:
The FDA 510(k) Clearance Process at 35 Years

At the request of the Food and Drug Administration, the Institute of Medicine examined the 510(k) clearance process, which requires device manufacturers to demonstrate that their new product is substantially equivalent to an already approved device. This report looks at that process, evaluating whether it optimally protects patients and promotes innovation in support of public health. It also identifies legislative, regulatory, or administrative changes that will achieve the goals of the 510(k) clearance process.

These series of briefings were for members of Congress and congressional staff only. The report was publicly released on July 28, 2011 and can be found, in its entirety, on the Web site of the National Academies Press.